Depression Screening: PHQ-9 Scores and What Comes Next
What does depression screening tell you?
Depression screening identifies symptoms that may need a fuller assessment. Questionnaires such as the PHQ-9 can organize information and help track change, but a score alone cannot diagnose depression, distinguish it from bipolar disorder or determine whether someone is safe. A useful screening process connects the result to a conversation, appropriate care and a clear follow-up plan.
Updated 24 September 2026. Educational information for adults, not a diagnostic test or an individualized treatment recommendation.
Screening, diagnosis and monitoring have different purposes
Screening asks whether further evaluation may be useful. Diagnosis considers whether a particular condition explains the symptom pattern and what other explanations need attention. Monitoring asks whether symptoms and functioning are changing over time. The same questionnaire may contribute to all three activities, but its role is not identical in each.
The US Preventive Services Task Force recommendation supports adult depression screening and emphasizes that positive results require further evaluation and, when appropriate, evidence-based care. It concerns preventive screening in people without an established disorder or recognized symptoms. Someone already struggling does not need to wait for a screening invitation to seek assessment.
Ask the service what happens after the form is completed. Who reviews it? When will you hear back? What should you do if symptoms worsen before that response? A questionnaire that ends with an automated label is not equivalent to a clinical consultation.
How the PHQ-9 works
The Patient Health Questionnaire-9 asks about nine symptom areas over the preceding two weeks. Each item is scored from zero to three, producing a total between zero and 27. It covers experiences such as low mood, reduced interest, sleep and appetite changes, low energy, concentration difficulties and thoughts about death or self-harm.
The original PHQ-9 validation study examined the questionnaire against clinical interviews and measures of functioning. The tool is useful because it offers a consistent way to describe symptoms, not because it replaces every part of an interview. Its accuracy also depends on the setting, population and how answers are interpreted.
Use the stated timeframe rather than answering only for your worst afternoon or your best morning. If an item is hard to interpret, make a note and discuss it. Completing the form honestly is more helpful than trying to obtain a particular score.
Understanding the usual score bands
Common PHQ-9 bands describe scores of zero to four as minimal, five to nine as mild, ten to 14 as moderate, 15 to 19 as moderately severe, and 20 to 27 as severe symptom levels. These are questionnaire categories, not stand-alone diagnoses or automatic instructions about medication, hospital admission or access to treatment.
The same total can arise from different combinations of answers. Two people can have similar scores while one is managing essential tasks and the other is not eating adequately or is experiencing a safety crisis. The individual answers and the discussion about their effects matter.
A change near a cutoff should not be treated as a dramatic transformation in the person. Moving from one band to another may be useful information, but interpretation should include functioning, distress and the overall trend. Our guide to depression severity explains why clinical severity is broader than a number.
A positive result is a reason to investigate, not a verdict
Screening tools are designed to identify possible problems, so some people with positive results will not meet criteria for major depression after assessment. Sleep deprivation, grief, physical illness, medication effects and other conditions may affect answers. These possibilities do not mean the symptoms are trivial.
A clinician may conclude that depression is present, that another condition is a better explanation, or that more information is needed. They should explain the reasoning and identify what support is appropriate now. There is no requirement to leave the appointment with every uncertainty resolved.
Do not independently start, increase or stop medication because of a result. Bring the completed questionnaire and any concerns to a qualified professional. The diagnosis guide describes the additional history that helps turn a screening result into a useful care plan.
A low score does not invalidate your concern
A person can need help even when their total falls below a service’s usual threshold. They may have answered cautiously, experienced symptoms outside the questionnaire’s timeframe or be struggling with something the form does not measure well. Difficulties with reading, language or interpreting questions can also affect responses.
Say directly when the result does not capture your experience. For example: ‘The score looks low, but I have stopped leaving home,’ or ‘I answered no because I did not understand what the question meant.’ A clinician should explore that discrepancy rather than treat the number as the final word.
Do not repeatedly retake a test until it produces a score that feels sufficiently serious. Describe the actual difficulties and request an assessment. You do not need to prove that you are worse than another person before receiving appropriate support.
Safety questions need a separate conversation
The PHQ-9 includes an item about thoughts of death or self-harm. Any concerning answer deserves discussion about what the person means, how current the thoughts are and what support is needed. A total score cannot determine suicide risk, and a negative answer does not override a direct statement that someone cannot stay safe.
The USPSTF’s uncertainty about universal suicide-risk screening in otherwise asymptomatic adults should not be interpreted as advice to ignore expressed suicidal thoughts. Preventive screening policy and responding to an actual concern are different questions. Seek urgent help when safety is deteriorating rather than waiting to complete another form.
Our guides to passive suicidal thoughts and depression and suicidal thoughts explain how to describe these experiences. Immediate danger requires local emergency services. An online screening website cannot provide an emergency response simply because you entered an answer.
Why clinicians ask about more than depression
A depressive episode can occur in bipolar disorder. The PHQ-9 does not establish whether someone has previously experienced mania or hypomania. Mention distinct periods of unusually increased energy, markedly reduced need for sleep or behavior that was very different from your usual self.
Assessment may also explore anxiety, trauma-related symptoms, substance use and physical health. These questions are not a diversion from your concern; they may change which treatment is suitable. The NIMH bipolar disorder information explains why the history across a person’s lifetime is important.
Prepare a medication list and a brief account of previous treatment. A form focused on the last fortnight cannot tell the clinician what helped, caused difficulties or occurred several years ago unless you add that information.
Preparing for the follow-up appointment
Bring three kinds of information: what changed, when it changed and what it prevents you from doing. You might describe losing interest in meals, needing much longer to complete familiar work or withdrawing from people you normally contact. Specific examples make a short appointment more useful.
Record relevant events without assuming they settle the diagnosis. A relationship breakdown can be important even when symptoms meet criteria for depression. Likewise, having no obvious trigger does not make the experience less understandable or less treatable.
Write down the question you most need answered. It could concern safety, a physical symptom, treatment choices or obtaining enough support to attend appointments. Ask for the agreed next steps in writing when concentration is difficult.
Accessibility and honest answers
Request an appropriate language version, an interpreter or help understanding the format when needed. Translated or adapted questions should be suitable for the purpose rather than improvised in a way that changes their meaning. Explain when literacy, vision, fatigue or cognitive difficulties interfere with completing the form.
You can also ask for private time to answer sensitive questions. A family member may be helpful with practical details, but their presence should not prevent you from describing experiences you are uncomfortable sharing in front of them.
For children, teenagers and pregnancy-related care, ask which assessment approach the service uses and why. Adult score bands should not simply be applied as a universal rule to every age group and situation.
Using scores to monitor treatment
Repeated measurement can provide a useful record when it is interpreted alongside everyday functioning. Try to use the same questionnaire and its stated timeframe. Explain major changes in sleep, health or circumstances that could affect the result.
Agree on a few personal indicators too: attending a planned activity, maintaining food intake or concentrating long enough to read something important. These examples are not extra diagnostic criteria. They help the clinician understand whether change is meaningful in your life.
Do not conceal worsening symptoms to appear cooperative or protect a therapist’s feelings. Monitoring is intended to improve care, including recognizing when the current approach is not sufficient.
Privacy and online screening tools
Before submitting sensitive answers online, check who operates the service, whether an account is required and how information may be used. A screening tool attached to advertising or a product funnel may serve a different purpose from one used within your clinical care.
Ask whether a clinician will actually review the answers. A message saying that your result is confidential does not explain whether information is shared with other services, retained for marketing or monitored for emergencies. Read the relevant privacy information rather than assuming all health-looking websites work alike.
You can discuss symptoms with a clinician without purchasing a report or sharing a result on social media. The useful outcome is appropriate assessment and support, not collecting a public label.
Frequently asked questions
Does a PHQ-9 score of ten mean I definitely have depression?
No. Ten is a commonly used screening threshold, but diagnosis requires the full clinical picture. Ask what the result means in the setting where you completed it.
Can I get support without completing a questionnaire?
Tell the service when a form is inaccessible or does not reflect your experience. Symptoms, functional difficulties and safety concerns still deserve a conversation and appropriate assessment.
How often should I repeat a screening test?
Agree on a useful schedule with your clinician rather than testing repeatedly for reassurance. A sudden deterioration or safety concern calls for contact with a service, not simply another score.
When not to wait for screening
Seek urgent clinical help for suicidal thoughts, new hallucinations, severe self-neglect or a rapid, marked change in mood and behavior. Immediate danger, severe confusion or an inability to maintain essential food or fluids can require emergency care. See crisis-support information for further signposting.
Continue exploring
Depression Treatment for Women: Choosing Appropriate Care
Compare depression care by clinical need, safety, reproductive health, treatment quality and practical access rather than relying on a women's-program label.
Treatment ComparisonsOne-to-One Depression Treatment: Private Therapy and Residential Care
Compare individual therapy, private bedrooms and one-client residences. Understand what one-to-one depression care includes, its limits and how to choose.
Treatment ComparisonsTreatment-Resistant Depression Centers: Comparing Specialist Care
Compare care for treatment-resistant depression by diagnostic review, actual specialist treatments, medical monitoring, evidence and long-term follow-up.